ATC code J05

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ATC codes
J Antiinfectives for systemic use
J01 Antibacterials for systemic use
J02 Antimycotics for systemic use
J04 Antimycobacterials
J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins
J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use
QJ54 Antimycobacterials for intramammary use

ATC code J05 Antivirals for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup J05 is part of the anatomical group J Antiinfectives for systemic use.[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QJ05...[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J05A Direct acting antiviral drugs[edit]

J05AA Thiosemicarbazones[edit]

J05AA01 Metisazone

J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors[edit]

J05AB01 Aciclovir
J05AB02 Idoxuridine
J05AB03 Vidarabine
J05AB04 Ribavirin
J05AB06 Ganciclovir
J05AB09 Famciclovir
J05AB11 Valaciclovir
J05AB12 Cidofovir
J05AB13 Penciclovir
J05AB14 Valganciclovir
J05AB15 Brivudine
J05AB54 Ribavirin, combinations

J05AC Cyclic amines[edit]

J05AC02 Rimantadine
J05AC03 Tromantadine

J05AD Phosphonic acid derivatives[edit]

J05AD01 Foscarnet
J05AD02 Fosfonet

J05AE Protease inhibitors[edit]

J05AE01 Saquinavir
J05AE02 Indinavir
J05AE03 Ritonavir
J05AE04 Nelfinavir
J05AE05 Amprenavir
J05AE07 Fosamprenavir
J05AE08 Atazanavir
J05AE09 Tipranavir
J05AE10 Darunavir
J05AE11 Telaprevir
J05AE12 Boceprevir

J05AF Nucleoside and nucleotide reverse transcriptase inhibitors[edit]

J05AF01 Zidovudine
J05AF02 Didanosine
J05AF03 Zalcitabine
J05AF04 Stavudine
J05AF05 Lamivudine
J05AF06 Abacavir
J05AF07 Tenofovir disoproxil
J05AF08 Adefovir dipivoxil
J05AF09 Emtricitabine
J05AF10 Entecavir
J05AF11 Telbivudine
J05AF12 Clevudine

J05AG Non-nucleoside reverse transcriptase inhibitors[edit]

J05AG01 Nevirapine
J05AG02 Delavirdine
J05AG03 Efavirenz
J05AG04 Etravirine
J05AG05 Rilpivirine

J05AH Neuraminidase inhibitors[edit]

J05AH01 Zanamivir
J05AH02 Oseltamivir

J05AR Antivirals for treatment of HIV infections, combinations[edit]

J05AR01 Zidovudine and lamivudine
J05AR02 Lamivudine and abacavir
J05AR03 Tenofovir disoproxil and emtricitabine
J05AR04 Zidovudine, lamivudine and abacavir
J05AR05 Zidovudine, lamivudine and nevirapine
J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
J05AR07 Stavudine, lamivudine and nevirapine
J05AR08 Emtricitabine, tenofovir disoproxil and rilpivirine
J05AR09 Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
J05AR10 Lopinavir and ritonavir
J05AR11 Lamivudine, tenofovir disoproxil and efavirenz

J05AX Other antivirals[edit]

J05AX01 Moroxydine
J05AX02 Lysozyme
J05AX05 Inosine pranobex
J05AX06 Pleconaril
J05AX07 Enfuvirtide
J05AX08 Raltegravir
J05AX09 Maraviroc
J05AX10 Maribavir
J05AX11 Elvitegravir
J05AX12 Dolutegravir

References[edit]

  1. ^ "ATC/DDD Index 2014: code J05". WHO Collaborating Centre for Drug Statistics Methodology. 
  2. ^ "ATCvet Index 2014: code QJ05". WHO Collaborating Centre for Drug Statistics Methodology.